Accel Research Sites named Tampa Bay Times Best of the Best 2023 finalist
Accel Research Sites has been named a finalist in the Tampa Bay Times Best of the Best 2023. Best of the Best… Read More
Studies related to: Accel Research Sites
Find a TrialAccel Research Sites named Tampa Bay Times Best of the Best 2023 finalist
Accel Research Sites has been named a finalist in the Tampa Bay Times Best of the Best 2023. Best of the Best… Read More
Accel Research Sites now enrolling for pediatric atopic dermatitis trial
Atopic dermatitis, more widely known as eczema, doesn’t have a cure. However, Accel Research Sites is testing a new drug that… Read More
Lora Parahovnik featured among Orlando Magazine’s 2023 Women Who Move the City
Lora Parahovnik, CEO of Accel Research Sites, was chosen as one of Orlando Magazine’s 2023 Women Who Move the City. Orlando… Read More
Accel Research Sites featured among 2023 Diversity in Business winners by OBJ
Accel Research Sites was chosen as one of the winners of Orlando Business Journal’s 2023 Diversity in Business Awards. The Orlando… Read More
Accel Research Sites honored with Diversity in Business Award from Orlando Business Journal
Accel Research Sites recognized by Orlando Business Journal as Outstanding Diverse Organization In the medical field, diversity is not just admirable—it’s… Read More
Accel to celebrate new St. Petersburg-Largo Location with ribbon-cutting, open house
Last month, we at Accel Research Sites Network were thrilled to announce the opening of our new St. Petersburg-Largo Location. Now,… Read More
Orlando Business Journal shares news of Accel acquisitions
The Orlando Business Journal recently highlighted Accel Research Sites’ acquisition of two new site locations. The sites, Ormond Medical Arts (OMA)-Pharmaceutical… Read More
Accel Research Sites Network is proud to announce a new partnership with VersaTrial. We have adopted VersaTrial’s Study Organizer and FQ… Read More